Source: Annual Congress 2010 - Pulmonary circulation I
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Safdar (Houston, United States Of America). Circulating collagen biomarker and quality of life in pulmonary arterial hypertension. Eur Respir J 2010; 36: Suppl. 54, 1113

Member's Comments

No comment yet.

Related content which might interest you: Circulating fibrocytes and pulmonary arterial hypertension Source: Eur Respir J 2011; 39: 210-212 Year: 2012 Circulating fibrocytes and pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 210-212 Year: 2012 Circulating fibrocytes in pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension Source: Eur Respir J 2011; 38: 608-616 Year: 2011 Measurement of quality of life in pulmonary hypertension and its significance Source: Eur Respir J 2006 Oct 01;28(4):808-815 Year: 2006 Sildenafil improves health-related quality of life in pulmonary arterial hypertension (PAH) patients Source: Eur Respir J 2005; 26: Suppl. 49, 563s Year: 2005 Pulmonary arterial hypertension: the burden of disease and impact on quality of life Source: Eur Respir Rev 2015; 24: 621-629 Year: 2015 LATE-BREAKING ABSTRACT: Circulating collagen indices indicative of disease severity in pulmonary arterial hypertension Source: Annual Congress 2012 - New insights in pneumology - ERS inter-Assemblies late-breaking abstracts Year: 2012 Health-related quality of life in patients with pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Effects of tadalafil on health-related quality of life in patients with pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009 Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Improving survival in pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 218-220 Year: 2005 Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR Source: Eur Respir J, 57 (2) 2000414; 10.1183/13993003.00414-2020 Year: 2021 Exercise tests and anxiety independently reflect physical quality of life in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Apelin improves cardiac output in patients with pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Effect of intravenous epoprostenol on quality of life in pulmonary arterial hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 563s Year: 2003 Circulating angiopoietins in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Plasma nitrite/nitrate levels: a new biomarker for pulmonary arterial hypertension? Source: Eur Respir J 2016; 48: 1265-1267 Year: 2016